Genome-wide meta-analysis of cerebral white matter hyperintensities in patients with stroke

Neurology

Volumn 86, Issue 2, 2016, Pages 146-153

  Traylor, Matthew ^a   Zhang, Cathy R ^b   Adib Samii, Poneh ^c   Devan, William J ^b   Parsons, Owen E ^a   Lanfranconi, Silvia ^b   Gregory, Sarah ^c   Cloonan, Lisa ^d   Falcone, Guido J ^b   Radmanesh, Farid ^b,e   Fitzpatrick, Kaitlin ^b   Kanakis, Allison ^b   Barrick, Thomas R ^c   Moynihan, Barry ^c   Lewis, Cathryn M ^f,g   Boncoraglio, Giorgio B ^h   Lemmens, Robin ^d,i,j,k,l   Thijs, Vincent ^a,i,j,k,l   Sudlow, Cathie ^m   Wardlaw, Joanna ^m   Rothwell, Peter M ⁿ   Meschia, James F ^o   Worrall, Bradford B ^o   Levi, Christopher ^p   Bevan, Steve ^p   Furie, Karen L ^q   Dichgans, Martin ^r   Rosand, Jonathan ^b,d   Markus, Hugh S ^a   Rost, Natalia ^b   more..

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF LONDON   (United Kingdom)

^d MAGGIORE HOSPITAL   (Italy)

^e BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g DEPARTMENT OF NEUROSURGERY   (Italy)

^h UNIVERSITY OF LEUVEN   (Belgium)

ⁱ UNIVERSITY OF MELBOURNE   (Australia)

^j UNIVERSITY OF EDINBURGH   (United Kingdom)

^k UNIVERSITY OF OXFORD   (United Kingdom)

^l MAYO CLINIC   (United States)

^m UNIVERSITY OF VIRGINIA   (United States)

ⁿ UNIVERSITY OF NEWCASTLE   (Australia)

^o UNIVERSITY OF LINCOLN   (United Kingdom)

^p BROWN UNIVERSITY   (United States)

^q LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^r Technische Universität München Munich Cluster for Systems Neurology   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AHCYL2 GENE; ARTICLE; AUSTRALIA; BELGIUM; BRAIN SIZE; C1QL1 GENE; CEREBROVASCULAR ACCIDENT; COL4A2 GENE; COMMUNITY LIVING; DISEASE COURSE; EFEMP1 GENE; EVL GENE; FEMALE; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HAAO GENE; HUMAN; HUMAN GENOME; IMAGING SOFTWARE; INDEPENDENT VARIABLE; ITALY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NBEAL1 GENE; NEURL GENE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PDCD11 GENE; PMF1 BGLAP GENE; PRIORITY JOURNAL; SH3PXD2A GENE; SINGLE NUCLEOTIDE POLYMORPHISM; STROKE PATIENT; TRIM65 GENE; UNITED KINGDOM; UNITED STATES; WHITE MATTER; CEREBROVASCULAR DISEASE; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; GENOME-WIDE ASSOCIATION STUDY; META ANALYSIS; PATHOPHYSIOLOGY; PROCEDURES; RISK FACTOR; STROKE;

CEREBRAL SMALL VESSEL DISEASES; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOME-WIDE ASSOCIATION STUDY; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; STROKE; WHITE MATTER;

EID: 84954318325     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000002263     Document Type: Article

References (30)

1. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2010;341:c3666.
2. Rost NS, Rahman RM, Biffi A, et al. White matter hyperintensity volume is increased in small vessel stroke subtypes. Neurology 2010;75:1670-1677.
3. Ay H, Arsava EM, Rosand J, et al. Severity of leukoaraiosis and susceptibility to infarct growth in acute stroke. Stroke 2008;39:1409-1413.
4. Arsava EM, Rahman R, Rosand J, et al. Severity of leukoaraiosis correlates with clinical outcome after ischemic stroke. Neurology 2009;72:1403-1410.
5. Atwood LD, Wolf PA, Heard-Costa NL, et al. Genetic variation in white matter hyperintensity volume in the Framingham Study. Stroke 2004;35:1609-1613.
6. Turner ST, Jack CR, Fornage M, Mosley TH, Boerwinkle E, de Andrade M. Heritability of leukoaraiosis in hypertensive sibships. Hypertension 2004;43: 483-487.
7. Carmelli D, DeCarli C, Swan GE, et al. Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. Stroke 1998;29: 1177-1181.
8. Opherk C, Peters N, Holtmannspotter M, Gschwendtner A, Muller-Myhsok B, Dichgans M. Heritability of MRI lesion volume in CADASIL: evidence for genetic modifiers. Stroke 2006;37:2684-2689.
9. Adib-Samii P, Devan W, Traylor M, et al. Genetic architecture of white matter hyperintensities differs in hypertensive and nonhypertensive ischemic stroke. Stroke 2015; 46:348-353.
10. Fornage M, Debette S, Bis JC, et al. Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium. Ann Neurol 2011;69:928-939.
11. Lopez LM, Hill WD, Harris SE, et al. Genes from a translational analysis support a multifactorial nature of white matter hyperintensities. Stroke 2015;46:341-347.
12. Verhaaren BF, Debette S, Bis JC, et al. Multi-ethnic genome-wide association study of cerebral white matter hyperintensities on MRI. Circ Cardiovasc Genet 2015;8: 398-409.
13. Schmidt R, Schmidt H, Haybaeck J, et al. Heterogeneity in age-related white matter changes. Acta Neuropathol 2011;122:171-185.
14. Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013;12:822-838.
15. Chen YW, Gurol ME, Rosand J, et al. Progression of white matter lesions and hemorrhages in cerebral amyloid angiopathy. Neurology 2006;67:83-87.
16. Grimaud J, Lai M, Thorpe J, et al. Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques. Magn Reson Imaging 1996;14:495-505.
17. Smith SM, Zhang Y, Jenkinson M, et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002;17:479-489.
18. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006;38:904-909.
19. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-575.
20. Abecasis GR, Auton A, Brooks LD, et al. An integrated map of genetic variation from 1,092 human genomes. Nature 2012;491:56-65.
21. Devlin B, Roeder K. Genomic control for association studies. Biometrics 1999;55:997-1004.
22. Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 2010;26:2190-2191.
23. de Bakker PI, Ferreira MA, Jia X, Neale BM, Raychaudhuri S, Voight BF. Practical aspects of imputation-driven meta-analysis of genome-wide association studies. Hum Mol Genet 2008;17:R122-R128.
24. Boyle AP, Hong EL, Hariharan M, et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res 2012;22:1790-1797.
25. The Genotype-Tissue Expression (GTEx) Project. Nat Genet 2013;45:580-585.
26. Rannikmae K, Davies G, Thomson PA, et al. Common variation in COL4A1/COL4A2 is associated with sporadic cerebral small vessel disease. Neurology 2015;84:918-926.
27. Dunham I, Kundaje A, Aldred SF, et al. An integrated encyclopedia of DNA elements in the human genome. Nature 2012;489:57-74.
28. Gould DB, Phalan FC, van Mil SE, et al. Role of COL4A1 in small-vessel disease and hemorrhagic stroke. N Engl J Med 2006;354:1489-1496.
29. Lanfranconi S, Markus HS. COL4A1 mutations as a monogenic cause of cerebral small vessel disease: a systematic review. Stroke 2010;41:e513-e518.
30. Jeanne M, Labelle-Dumais C, Jorgensen J, et al. COL4A2 mutations impair COL4A1 and COL4A2 secretion and cause hemorrhagic stroke. Am J Hum Genet 2012;90:91-101.